Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties

被引:0
|
作者
Kuz'mina N.E. [1 ]
Osipova E.S. [1 ]
Kuz'min V.S. [1 ]
Sitnikov V.B. [1 ]
机构
[1] State Research Institute of Organic Chemistry and Technology, Moscow
关键词
High Occupied Molecular Orbital; Binding Pocket; Tyramine; Molecular Descriptor; Proton Donor;
D O I
10.1007/s11094-006-0104-9
中图分类号
学科分类号
摘要
A comparative analysis of correlations between the ED50 and AD50 values describing the agonist and antagonist properties of opioid receptor ligands, on the one hand, and molecular descriptors related to the electronic and geometric properties of the tyramine moiety of these ligands, on the other hand, has been carried out. The affinity of ligands to the complementary site of opioid receptors depends on the electronic properties of the tyramine moiety, such as the basicity of the TF nitrogen atom, the electron-acceptor properties of the "cation head," the electron-donor properties of the aryl moiety, and the ability of substituent atoms in the aryl moiety to act as proton donors and form hydrogen bonds with the OR. The intrinsic activity of ligands depends on the coplanarity of atoms of the substituent in the aryl moiety to the phenyl ring plane. Substantial protrusion of substituent atoms out of the plane of the phenyl ring apparently prevents penetration of a ligand deep into "binding pocket" of the receptor, which leads to disappearance of the antagonist properties of this ligand. © 2006 Springer Science+Business Media, Inc.
引用
收藏
页码:254 / 260
页数:6
相关论文
共 50 条
  • [21] Receptor binding properties and antinociceptive effects of chimeric peptides consisting of a μ-opioid receptor agonist and an ORL1 receptor antagonist
    Kawano, Susumu
    Ito, Risa
    Nishiyama, Miharu
    Kubo, Mai
    Matsushima, Tomoko
    Minamisawa, Motoko
    Ambo, Akihiro
    Sasaki, Yusuke
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (07) : 1260 - 1264
  • [22] Effects of kappa opioid receptor agonist and antagonist on the aversive effects of nicotine
    DSouza, Manoranjan S.
    Ward, Melissa
    Norman, Haval
    FASEB JOURNAL, 2016, 30
  • [23] Switching agonist/antagonist properties of opiate alkaloids at the δ opioid receptor using mutations based on the structure of the orphanin FQ receptor
    Meng, F
    Wei, Q
    Hoversten, MT
    Taylor, LP
    Akil, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) : 21939 - 21945
  • [24] Development of bifunctional mu opioid receptor (MOR) agonist/delta opioid receptor (DOR) antagonist peptides and peptidomimetics
    Mosberg, Henry I.
    Anand, Jessica
    Bender, Aaron
    Harland, Aubrie A.
    Sobczyk-Kojiro, Katarzyna
    Yeomans, Larisa
    Jutkiewicz, Emily M.
    Traynor, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [25] Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
    Levy-Cooperman, N.
    McIntyre, G.
    Bonifacio, L.
    McDonnell, M.
    Davenport, J. M.
    Covington, P. S.
    Dove, L. S.
    Sellers, E. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 359 (03): : 471 - 481
  • [26] Novel Potent and Selective σ Ligands: Evaluation of Their Agonist and Antagonist Properties
    Marrazzo, Agostino
    Cobos, Enrique J.
    Parenti, Carmela
    Arico, Giuseppina
    Marrazzo, Giuseppina
    Ronsisvalle, Simone
    Pasquinucci, Lorella
    Prezzavento, Orazio
    Coabufo, Nicola A.
    Contino, Marialessandra
    Gonzalez, Luis G.
    Scoto, Giovanna M.
    Ronsisvalle, Giuseppe
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (10) : 3669 - 3673
  • [27] Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity
    Lucini, V
    Pannacci, M
    Scaglione, F
    Fraschini, F
    Rivara, S
    Mor, M
    Bordi, F
    Plazzi, PV
    Spadoni, G
    Bedini, A
    Piersanti, G
    Diamantini, G
    Tarzia, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) : 4202 - 4212
  • [28] UT RECEPTOR LIGANDS. SWITCHING FROM AGONIST TO ANTAGONIST ACTIVITY
    Carotenuto, A.
    Grieco, P.
    Campiglia, P.
    Marinelli, L.
    Novellino, E.
    Rovero, P.
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 221 - 221
  • [29] Longitudinal Measurement of Opioid Receptor Occupancy from Sustained Release Naltrexone: Comparison of Agonist, Partial Agonist and Antagonist Opioid Receptor Radiotracers in Rats
    Reed, B.
    Schoultz, B.
    Coello, C.
    Hjornevik, T.
    Lindblom, I.
    Henriksen, G.
    Willoch, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S266 - S266
  • [30] Comparative study of addiction liability of mixed agonist/antagonist and classical opioid ligands in mice
    Gharagozlou, P
    Modanlou, S
    Clark, DJ
    Lameh, J
    DeLorey, T
    FASEB JOURNAL, 2003, 17 (04): : A199 - A199